VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer

Contributed by: Business Wire

Logo

Images

VahatiCor CEO, Harry D. Rowland, Ph.D.

Business Wire embedded0

Tags

General Health

Medical Devices

Other Health

Health

Cardiology

Chief

More Like This

PR Newswire associated0

Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System

CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients

PR Newswire associated0

ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM

PR Newswire associated0

Volta Medical Appoints Bill Hoffman as Executive Chairman of the Board of Directors

Chris O'Connell, Chairman, Board of Directors, CorFlow

CorFlow Therapeutics Appoints Chris O'Connell as Chairman of the Board of Directors

PR Newswire associated0

Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure

PR Newswire associated0

Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results for its Cordella Pulmonary Artery Sensor

PR Newswire associated0

Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial